**Patients**

86 adult patients (F = 46, M = 40) with verified HH and long- standing Intermittent Oesophageal Disease (IED) and other Gastro Oesophageal Reflux Disease (GERD) symptoms.

Before entry into the study the patients were partitioned into three groups according to BMI (**Table 2**):

	- normal weight, BMI <sup>&</sup>lt; <sup>25</sup>

*Introducing an Innovative Oral Neuromuscular Treatment of the Underlying Reason… DOI: http://dx.doi.org/10.5772/intechopen.96773*

	- moderately obese, BMI 25–29
	- (n = 28: 16 women of median age 59 yrs., 12 men of median age 56 yrs.)
	- GERD symptoms median duration 6 yrs. (1–15).
	- PPI medication history median 6 yrs.
	- severely obese, BMI 30–<sup>37</sup>
	- (n = 21: 11 women of median age 52 yrs., 10 men of median age 70 yrs.
	- GERD symptoms median duration 3 yrs. (1–29).
	- PPI medication history median 3 yrs.
